Oxford Cancer has been launched to represent and coordinate cancer research in Oxford.
The pan-divisional initiative has been launched at the University of Oxford, bringing together the collective force of cancer research, outreach and care that happen across the city.
With more than 900 cancer-related researchers across five Oxford University Hospitals (OUH) and University divisions, Oxford staff are uniquely placed to solve key cancer research challenges through their innovative research discoveries.
The Oxford Cancer research theme will demonstrate the role Oxford researchers play in delivering cutting-edge research dedicated to tackling one of the biggest causes of death worldwide.
Together, the University and OUH have strengths in a wide variety of areas, including immunology, data science, cell biology, physical science and drug development. Oxford Cancer aims to bring this expertise together to facilitate multi-disciplinary research across its partners.
It ultimately aims to solve the key challenges cancer represents through developing and delivering novel strategies for early detection and curative treatment of a range of different cancer types. This approach will be informed by the latest fundamental scientific discoveries and underpinned by world leading data science and technological developments that are unique to Oxford.
This new network will not only facilitate University of Oxford and OUH staff with their work, it will also break down the barriers to research facilities and the expertise that can help researchers achieve greater impact for their discoveries.
Oxford Cancer has resources available to all Oxford researchers who feel their work is relevant to cancer research. They are encouraged to join the Oxford Cancer community to benefit from these services and received the monthly newsletter with cancer research and Oxford updates.
Professor Mark Middleton, the NIHR Oxford BRC Co-theme Lead for Cancer and co-Director of Oxford Cancer, said: “We are very excited to launch the new Oxford Cancer network, with the aim of bringing together all those with a shared interest in cancer, to address urgent and emerging cancer patient needs, informed by the best basic science.”